Dana Laake and her special guest Dr. Christine Horner will discuss how to increase survival and/or prevent prostate and breast cancer.
Christine Horner, MD, is a nationally recognized surgeon, author, professional speaker and a relentless champion for women’s health. She is board certified in both general and plastic surgery. Dr. Horner was recognized as a leader in her field shortly after starting her plastic and reconstructive surgery practice because she successfully ran a national campaign to pass laws requiring insurance companies to pay for breast reconstruction following mastectomy.
Dana Laake and her special guest Steven Nadell will discuss the latest news on how antioxidants may affect cancer cells, and the role and benefit of using nicotinamide riboside.
Steven Nadell, MS, CNS is a Functional Medicine Consultant with Thorne Research. He has been in the field of nutrition for 22 years. As a Certified Nutrition Specialist he helps doctors, nutritionists, and licensed practitioners use nutrition to improve patients’ health outcomes. He also supports the implementation of OncoQOL into oncology practices. OncoQOL are targeted nutraceuticals for helping to reduce side effects and improve quality of life for patients with cancer undergoing chemotherapy and radiation.
Dana Laake and her special guest Dr. Duffy MacKay will be discussing the recent media coverage of a study that suggests a higher risk of prostate cancer among men who eat omega-3 fatty acids.
Dr. MacKay leads Scientific and Regulatory Affairs for the Council for Responsible Nutrition (CRN), the leading trade association representing dietary supplement manufacturers and ingredient suppliers. Dr. MacKay also serves on several advisory and editorial boards including the American Botanical Council, and the United States Pharmacopeia. Dr. MacKay maintains a part-time practice where he assists patients with integrating naturopathic medicine into their lives to support health, wellness, and chronic disease management.
Dr. Kevin Passero and his special guest Dr. Sreenivas Rao will be discussing nutritional support for cancer patients. DaxibeQOL, a product by Thorne Research, will be featured; it is a blend of branched-chain and other essential amino acids known to possibly promote anabolism, weight gain, lean muscle mass, and muscle strength.
Dr. Sreenivas Rao has successfully managed programs for major pharmaceutical companies since 1994. He is currently president of OncoQOL, a joint business effort between two of the world’s leading healthcare companies, Helsinn and Thorne Research, Inc. OncoQOL’s mission is to provide pure, safe, evidence-based nutritional supplements and personal care products, together with information and education for medical professionals, patients, and caregivers.
Dana Laake and her guest Dr. Nicholas Gonzalez will be discussing the Gonzalez approach to cancer.
Nicholas J. Gonzalez, M.D., graduated from Brown University, Phi Beta Kappa, magna cum laude, with a degree in English Literature. He subsequently worked as a journalist, first at Time Inc., before pursuing premedical studies at Columbia. He then received his medical degree from Cornell University Medical College in 1983. During a postgraduate immunology fellowship under Dr. Robert A. Good, considered the father of modern immunology, he completed a research study evaluating an aggressive nutritional therapy in the treatment of advanced cancer. Since 1987, Dr. Gonzalez has been in private practice in New York City, treating patients diagnosed with cancer and other serious degenerative illnesses. His nutritional research has received substantial financial support from Procter & Gamble, Nestle, and the National Cancer Institute. Results from a pilot study published in 1999 described the most positive data in the medical literature for pancreatic cancer.
Dana Laake and her special guest Victoria Wood will be discussing the use of branched-chain amino acids in cancer and anti-aging.
Victoria Wood, MPH, RD, CNS, has been practicing Medical Nutrition Therapy (MNT) for over 25 years. She specializes in designing programs for optimal genetic expression for a wide array of conditions.
Host Dr. Kevin Passero and his special guest Dr. Cheryl K. Burdette will be discussing integrative oncology.
Dr. Cheryl K. Burdette, ND is a member of the Board of Advisors for Xymogen. She is also president and education director of NutraTest Labs where she is involved in clinical trials of nutraceutical products and the development of functional testing profiles. This position gives her a unique perspective in evidence-based natural therapies.